Marietta

Bandwidth IG Creates Advanced Network Capabilities for Digital Realty's Silicon Valley, Atlanta Data Centers on PlatformDIGITAL®

Retrieved on: 
Monday, August 30, 2021

Bandwidth IG's dark fiber solutions will advance Digital Realty's capabilities by offering hyper-scale, high-quality network infrastructure for digitally transformed businesses in two key markets.

Key Points: 
  • Bandwidth IG's dark fiber solutions will advance Digital Realty's capabilities by offering hyper-scale, high-quality network infrastructure for digitally transformed businesses in two key markets.
  • Bandwidth IG currently reaches 13 Digital Realty data centers in Silicon Valley, including its newly announced facility, which is under development at 641 Walsh in Santa Clara.
  • In Atlanta, Bandwidth IG currently provides diverse connectivity to all Digital Realty locations.
  • Bandwidth IG's 100% underground network meets critical data needs for enterprises and data centers who require quality, reliable connectivity options.

MIMEDX Announces Filing of Shelf Registration Statement with Securities and Exchange Commission

Retrieved on: 
Friday, August 27, 2021

MARIETTA, Ga., Aug. 27, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced the filing of a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC). Once declared effective by the SEC, the shelf registration statement will allow the Company to sell up to $350 million of various types of securities over the next three years.

Key Points: 
  • The filing of a shelf registration statement is a common practice by Nasdaq-listed companies.
  • The shelf registration statement relating to the securities has been filed with the SEC but has not yet become effective.
  • Once declared effective by the SEC, the shelf registration statement will be in effect for a period of three years, or such shorter period that the securities registered under the shelf registration statement have been issued or sold.
  • Statements regarding potential SEC approval of the shelf registration statement, potential securities issuances, and the results of clinical trials are forward-looking statements.

Yamaha Outdoor Access Initiative and Recreate Responsibly Coalition Partner to Ensure Access to Public Lands for Outdoor Recreation

Retrieved on: 
Tuesday, August 24, 2021

Recreate Responsibly and the Yamaha Outdoor Access Initiative are working together to educate and raise awareness of responsible use of trails and open spaces for motorized and outdoor recreation, said Steve Nessl, Yamahas Motorsports marketing manager.

Key Points: 
  • Recreate Responsibly and the Yamaha Outdoor Access Initiative are working together to educate and raise awareness of responsible use of trails and open spaces for motorized and outdoor recreation, said Steve Nessl, Yamahas Motorsports marketing manager.
  • The Yamaha Outdoor Access Initiative was created specifically to help those who see the need to protect or expand access to public land and need some support to get it done.
  • Part of the collaborative effort will raise funds for the Recreate Responsibly Coalition to bolster its focus on safe, accessible, inclusive, and responsible outdoor recreation.
  • For specific questions about the Yamaha Outdoor Access Initiative, call the dedicated hotline at 1-877-OHV-TRAIL (877-648-8724) or email [email protected].

Atlanta's Warm, Humid Weather Prolongs Mosquito Season into October

Retrieved on: 
Friday, August 20, 2021

What most people dont realize, however, is that summer is only the beginning of mosquito season and these pests are likely to be seen well into fall in most parts of the Georgia.

Key Points: 
  • What most people dont realize, however, is that summer is only the beginning of mosquito season and these pests are likely to be seen well into fall in most parts of the Georgia.
  • Although many consider mosquitoes to be a summer pest, these insects tend to hang around until October, said Natasha Oldham, general manager.
  • Mosquitoes remain active until the temperatures drop below 60 degrees, something that doesnt happen consistently in metro Atlanta until October.
  • Enter for a chance to win a free mosquito treatment by visiting us on Instagram .

Medicare Data: Significant Reductions in Amputations, Emergency Visits, and Hospital Readmissions Associated with Advanced Treatment Using Skin Substitute Products for Lower Extremity Diabetic Ulcers (LEDUs)

Retrieved on: 
Tuesday, August 17, 2021

MARIETTA, Ga., Aug. 17, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced publication of its peer-reviewed study in the Journal of Wound Care (JWC), addressing the observed impact of Advanced Treatment (AT) using all high-cost skin substitute products in lower extremity diabetic ulcers (LEDUs) based on data from the Medicare Limited Dataset (October 1, 2015 through October 2, 2018). The study assessed outcome in patients receiving AT with all high-cost skin substitute products, as designated by the Centers for Medicare and Medicaid Services (CMS), for LEDUs versus No Advanced Treatment (NAT), and found that AT use could lead to a 42% reduction in major and minor amputations and all related costs, compared to NAT. Further, the study highlights preferable outcomes when AT follows parameters for use (FPFU), underscoring the importance of early treatment with regular intervals and well-defined treatment guidelines.

Key Points: 
  • Further, the study highlights preferable outcomes when AT follows parameters for use (FPFU), underscoring the importance of early treatment with regular intervals and well-defined treatment guidelines.
  • In 2018, an estimated three million Americans suffered from diabetic foot ulcers (DFUs) a type of LEDU.
  • The immediate physical and economic toll on people with diabetic lower extremity complications, including amputations, have been correlated to an increased five-year mortality rate.
  • We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION process.

Trutech Wildlife Service reminds homeowners fall is the ideal time to humanely protect your home from bats

Retrieved on: 
Monday, August 16, 2021

ORLANDO, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Trutech Wildlife Service, the leading wildlife removal company, stresses to Florida homeowners that humane bat removal began Aug. 15, 2021.

Key Points: 
  • ORLANDO, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Trutech Wildlife Service, the leading wildlife removal company, stresses to Florida homeowners that humane bat removal began Aug. 15, 2021.
  • The federal mandates and additional maternity protections are due to declining populations and the benefits that bats provide .
  • After Aug. 15, exclusion devices can be installed to remove bats from inside residential and commercial structures.
  • If you notice these signs but cannot find bats present, make sure to protect your home by sealing all potential entry points.

Yamaha Celebrates 4 Million Units Assembled in the USA

Retrieved on: 
Thursday, August 12, 2021

Over the past 20 years, Yamaha has invested more than $380 million into U.S. manufacturing to create a world-class facility in Newnan, said Taka Imanishi, president of YMMC.

Key Points: 
  • Over the past 20 years, Yamaha has invested more than $380 million into U.S. manufacturing to create a world-class facility in Newnan, said Taka Imanishi, president of YMMC.
  • The facility covers 280 acres with more than 1.3 million square feet of manufacturing facilities, giving it a massive physical footprint in Newnan.
  • REALize Your Adventure and learn more about Yamahas full lineup of vehicles Assembled in the USA at YamahaOutdoors.com , or by visiting your local Yamaha dealer.
  • Yamaha Motor Corporation, USA (YMUS), is a recognized leader in the outdoor recreation industry.

MIMEDX Promotes Marion Snyder to Chief of Staff, Senior Vice President, Government Affairs

Retrieved on: 
Thursday, August 12, 2021

MARIETTA, Ga., Aug. 12, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced the promotion of Marion Snyder to Chief of Staff, Senior Vice President, Government Affairs. As a member of the Senior Leadership Team, Ms. Snyder will oversee strategic projects requiring cross-functional input, and drive the integration, effectiveness, and efficiency of decision making throughout the organization to advance multiple, company-wide initiatives. She will continue in her role as co-chair of the Company’s Inclusion and Diversity Council and serve as an important voice for MIMEDX’s government affairs and patient advocacy efforts. As a policy contributor and trusted advisor, she will serve as a significant communications link with the broader organization as a whole. With this promotion, the Company has commenced an executive search to fill Ms. Snyder’s prior role of Senior Vice President, Market Access.

Key Points: 
  • MARIETTA, Ga., Aug. 12, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced the promotion of Marion Snyder to Chief of Staff, Senior Vice President, Government Affairs.
  • With this promotion, the Company has commenced an executive search to fill Ms. Snyders prior role of Senior Vice President, Market Access.
  • Timothy R. Wright, MIMEDX Chief Executive Officer, said, As leaders, we have an opportunity each day to make a difference for patients.
  • Ms. Snyder joined MIMEDX in 2013, and throughout her eight-year tenure she has continued to take on roles of increasing responsibility, most recently serving as Senior Vice President, Market Access.

MIMEDX Announces Second Quarter 2021 Operating and Financial Results

Retrieved on: 
Tuesday, August 3, 2021

MARIETTA, Ga., Aug. 03, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced the filing of its second quarter 2021 Form 10-Q for the period ended June 30, 2021.

Key Points: